登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C16H14ClN3O2
化学文摘社编号:
分子量:
315.75
UNSPSC Code:
51111800
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
Tyrphostin AG 1478(酪氨酸激酶抑制剂AG 1478), ≥98%
Quality Level
assay
≥98%
form
solid
solubility
0.1 M HCl: soluble <0.4 mg/mL, DMSO:methanol (1:1): soluble 10 mg/mL, clear, colorless, ethanol: soluble 10 mg/mL, methylene chloride: soluble 10 mg/mL, 0.1 M NaOH: insoluble, 2-hydroxypropyl-β-cyclodextrin: insoluble, H2O: insoluble
storage temp.
2-8°C
SMILES string
COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC
InChI
1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)
InChI key
GFNNBHLJANVSQV-UHFFFAOYSA-N
Gene Information
human ... EGFR(1956)
mouse ... Egfr(13649)
Application
酪氨酸磷酸化抑制剂AG 1478已用作表皮生长因子受体(EGFR)酪氨酸激酶抑制剂,用于研究其在boyden小室迁移检测中对硬纤维瘤细胞迁移的影响。它还用于抑制A431表皮样癌细胞株中外源性转化生长因子α介导的磷酸化。
Biochem/physiol Actions
酪氨酸磷酸化抑制剂AG 1478是一种表皮生长因子受体(EGFR)酪氨酸激酶抑制剂。它可导致大鼠的低镁血症和心功能障碍发展。酪氨酸磷酸化抑制剂AG 1478是乳腺癌的潜在治疗剂。
表皮生长因子受体蛋白选择性抑制剂
Features and Benefits
该化合物是激酶磷酸酶生物学研究的特色产品。 点击此处 ,发现更多特色激酶磷酸酶生物学产品。在 sigma.com/discover-bsm了解更多关于其他研究领域的生物活性小分子。
Preparation Note
酪氨酸磷酸化抑制剂 AG 1478 溶于 DMSO:MeOH (1:1),浓度为 10 mg/mL,得到澄清、无色溶液。也可溶于二氯甲烷 (10 mg/mL)、乙醇 (10 mg/mL) 和 0.1 NHCl(低于 0.4 mg/mL)。但不溶于水、2-羟丙基-β-环糊精和 0.1n NaOH。
Still not finding the right product?
Explore all of our products under Tyrphostin AG 1478(酪氨酸激酶抑制剂AG 1478)
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
商品
Discover Bioactive Small Molecules for Kinase Phosphatase Biology
Desmoid cell motility is induced in vitro by rhEGF
Joyner DE, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society, 27(9), 1258-1262 (2009)
The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction
Weglicki WB, et al.
Canadian Journal of Physiology and Pharmacology, 56, 8-8 (2019)
Sandra Rayego-Mateos et al.
The Journal of pathology, 244(2), 227-241 (2017-11-22)
Connective tissue growth factor (CCN2/CTGF) is a matricellular protein that is overexpressed in progressive human renal diseases, mainly in fibrotic areas. In vitro studies have demonstrated that CCN2 regulates the production of extracellular matrix (ECM) proteins and epithelial-mesenchymal transition (EMT)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| T4182-5MG | 04061837345647 |
| T4182-1MG | 04061837345616 |